Drugs / lopinavir/ritonavir
last change Jun 2010 re-read 2 minutes ago

lopinavir/ritonavir

Developed for
HIV infectious disease
Investigated by
Abbott · Saint Michael's Medical Center

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00752037 Sep 2008 → Apr 2010 HIV infectious disease Saint Michael's Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as lopinavir/ritonavir ClinicalTrials.gov intervention name — accepted as the source's own label NCT00752037
Route Oral “lopinavir/ritonavir 400/100 mg po b.id.” NCT00752037